Company Filing History:
2 out of 7 
1 out of 29 
1 out of 21 Years Active: 1993-2012
Title: Larry B Kulesa: Innovator in Medical Technology
Introduction
Larry B Kulesa, based in Bothell, WA, is an accomplished inventor with a notable portfolio of four patents in the field of medical technology. His innovative contributions have paved the way for advancements in patient treatment systems, particularly in cardiac procedures.
Latest Patents
Among his latest patents are "Tissue-penetrating guidewires with shaped tips, and associated systems and methods." This invention presents a patient treatment system that includes a flexible guidewire with a penetrating member at its distal portion, designed for enhanced performance in tissue penetration. The guidewire can be connected to an electrical current source, allowing for the delivery of high-frequency current to aid in medical procedures.
Another significant patent is for "Systems and methods for transeptal cardiac procedures." This method outlines a strategy for positioning a tissue-penetrating guidewire adjacent to the cardiac septum, utilizing energy pulses to facilitate its advancement through the septum in a series of discrete steps. Following this, a catheter can be passed over the guidewire, marking a critical advancement in cardiac treatments.
Career Highlights
Larry has worked with reputable companies such as Coaptus Medical Corporation and Aculight Corporation, where he has gained extensive experience in developing medical devices and technologies. His career reflects a commitment to improving patient care through innovative solutions.
Collaborations
Throughout his journey, Larry has collaborated with skilled professionals, including Ryan E Kaveckis and David C Auth, who have contributed to the development of groundbreaking medical technologies alongside him.
Conclusion
Larry B Kulesa’s inventive spirit and dedication to medical innovation continue to have a significant impact on the field. His contributions through patents and collaborations reflect a profound commitment to enhancing treatment methodologies, ultimately improving outcomes for patients.